日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation

谷胱甘肽还原酶2通过调节线粒体通透性转换孔对急性髓系白血病(AML)细胞的存活至关重要。

Ling, Tianyi; O'Brien, Cristiana; St-Germain, Jonathan R; Rondeau, Vincent; Shi, Mary; Berman, Jacob M; Cepa, Adrianna; Saez Raez, Paula; Wunderlich, Mark; Carter, Katharine M; Stillwell, Cody; Sexton, Christina; Culp-Hill, Rachel; Reisz, Julie A; Adeel, Saeer A; Zeng, Andy G X; Bansal, Suraj; Tsao, Emily; Chen, He Tian; Dick, John E; Minden, Mark D; Arruda, Andrea; Amaya, Maria L; Tikhonova, Anastasia N; Hope, Kristin J; D'Alessandro, Angelo; Raught, Brian; Jones, Courtney L

Blood-based epigenetic instability linked to human aging and disease

血液中表观遗传不稳定性与人类衰老和疾病相关

Basrai, Salman; Nofech-Mozes, Ido; Detroja, Rajesh; Scolari, Fernando L; Bakhtiari, Mehran; Arruda, Andrea; Murphy, Tracy; Bratman, Scott V; Chan, Steven M; Minden, Mark D; Sook Ahn, Jae; Kim, Dennis D H; Kridel, Robert; Billia, Filio; Abelson, Sagi

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia

LSC17评分在预测新诊断急性髓系白血病患者风险方面的真实世界验证研究

Murphy, Tracy; Zhang, Boyang; Zhang, Tong; King, Ian; Capo-Chichi, Jose-Mario; Gupta, Vikas; Maze, Dawn; McNamara, Caroline J; Minden, Mark D; Schimmer, Aaron D; Schuh, Andre C; Sibai, Hassan; Yee, Karen W L; Arruda, Andrea; Lu, Zhibin; Khalaf, Dina; Rockwell, Chantal; Leber, Brian; Sabloff, Mitchell; Tierens, Anne; Stockley, Tracy L; Chan, Steven M; Ng, Stanley W K; Wang, Jean C Y

A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneity

用于靶向AML表面异质性的免疫治疗的多模态图谱

Ung, Matthew; Etchin, Julia; Halfond, Amanda; DiFazio, Julia; Keschner, Yonina; Pyclik, Alyssa; Campbell, Anne; Wang, Ruijia; Silva, Mariana; Gjeci, Brikena; Montalbano, Antonino; Williams, Reid; Mundelboim, Guy; Arruda, Andrea; Minden, Mark; Scherer, Julian; Chakraborty, Tirtha; Ge, Huanying Gary; Lydeard, John R

Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT

接受儿科方案衍生的多药化疗方案联合酪氨酸激酶抑制剂(TKI)治疗的费城染色体阳性B细胞急性淋巴细胞白血病成人患者,无需常规进行异基因造血干细胞移植(alloSCT)。

Eng, Donna Zhe Sian; Khadadah, Fatima; Perusini, Maria Agustina; Al-Shaibani, Eshrak; Atenafu, Eshetu G; Bankar, Aniket; Davidson, Marta; Richard-Carpentier, Guillaume; Maze, Dawn; Yee, Karen; Schimmer, Aaron; Gupta, Vikas; Chan, Steven; Kim, Dennis Dong Hwan; Schuh, Andre; Minden, Mark; Sibai, Hassan

Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors

利用IDH抑制剂治疗AML的PDX模型进行克隆演化的单细胞蛋白质组学分析

Liu, Alex C H; Cathelin, Severine; Manikoth Ayyathan, Dhanoop; Yang, Yitong; Aboualizadeh, Farzaneh; Abow, Amina; Basi, Gurbaksh; Li, Lance; Dai, David L; Maher, Abdula; Grignano, Eric; Hosseini, Mohsen; Wang, Vivian; Ketela, Troy; Nicolay, Brandon; Marchione, Dylan M; Tron, Adriana E; Arruda, Andrea; Minden, Mark D; Chan, Steven M

CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias

MECOM对CEBPA的抑制作用会阻断分化,从而驱动侵袭性白血病的发生。

Fleming, Travis J; Antoszewski, Mateusz; Lambo, Sander; Gundry, Michael C; Piussi, Riccardo; Wahlster, Lara; Shah, Sanjana; Reed, Fiona E; Dong, Kevin D; Paulo, Joao A; Gygi, Steven P; Mimoso, Claudia; Goldman, Seth R; Adelman, Karen; Perry, Jennifer A; Pikman, Yana; Stegmaier, Kimberly; Barrachina, Maria N; Machlus, Kellie R; Hovestadt, Volker; Arruda, Andrea; Minden, Mark D; Voit, Richard A; Sankaran, Vijay G

Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes

基于血液的蛋白质组学分析发现OSMR是AML预后的新型生物标志物。

Reville, Patrick K; Wang, Bofei; Marvin-Peek, Jennifer; Yuan, Bin; Kuo, Yu-An; Garza, Araceli; Root, Jessica; Qiao, Wei; Arruda, Andrea; Veletic, Ivo; Liu, Yiwei; Short, Nicholas J; DiNardo, Courtney D; Kadia, Tapan M; Daver, Naval G; Lorenzi, Philip L; Sasaki, Koji; Kornblau, Steven; Minden, Mark D; Ravandi, Farhad; Kantarjian, Hagop M; Abbas, Hussein A

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

FLT3对于ITD突变的白血病干细胞而言是基因必需的,但对于人类造血干细胞而言则并非必需。

Araújo, Joana L; Wagenblast, Elvin; Voisin, Veronique; McLeod, Jessica; Gan, Olga I; Bansal, Suraj; Jin, Liqing; Mitchell, Amanda; Gratton, Blaise; Cutting, Sarah; Arruda, Andrea; Doedens, Monica; Travas, Anthea; Kim, Dennis; Capo-Chichi, Jose-Mario; Abelson, Sagi; Minden, Mark D; Wang, Jean C Y; Sobrinho-Simões, Manuel A; Pinto-do-Ó, Perpétua; Lechman, Eric; Dick, John E

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

血浆脂质水平可预测急性髓系白血病患者的化疗反应和生存期

O'Brien, Cristiana; Nursimulu, Nirvana; Tyagi, Anit; Culp-Hill, Rachel; Arruda, Andrea; Murphy, Tracy; Minden, Mark D; Kent, Andrew; Stevens, Brett; Pollyea, Daniel A; Hope, Kristin; Kumar, Sushant; Reisz, Julie A; D'Alessandro, Angelo; Jones, Courtney L